Get emailed when SGMO changes direction
Factor Model (net -3.2)
Factor Model
net -3.2
Est. Revisions
-1.0
Insider Activity
+0.0
Momentum
+0.0
Analyst Rev.
-1.0
Narrative Gap
+0.0
Analysis pending — waiting for first signal cycle.
Evidence
Fundamentals & Data ▾
Sangamo Therapeutics, Inc.
Healthcare · Biotechnology
Mkt Cap
$83M
Beta
1.50
52w Range
$0.14 - $0.79
Short Interest
42.9M 10.42%
Days to Cover
5.5 +28%
Technicals
downtrend
from 52w Hi
-30.8%
1w return
-14.3%
Insiders
selling
0B / 2S
EPS Estimate
$-0.07
-75.0% 30d
0up / 1dn
Est. Dispersion
57%
2 analysts
Analyst Target
$4
$1 - $10
Options P/C
0.02
Fund Convergence
strong
Renaissance, Two Sigma, Citadel
Financials
Revenue
$14M +88% YoY
FCF
$-24M
Op Margin
-176%
Momentum:
accelerating
Top Holders
Renaissance
$4M
Two Sigma
$2M
Citadel
Recent Filings & Data
insider trade
15
net selling
· $106,878 sold
13 insiders · 15 transactions (30d)
Recent transactions
DAVIS GREGORY D · sell · $17,694
DUBOIS-STRINGFELLOW NATHALIE · sell · $89,184
BEERS COURTNEY · award
MARKELS JOHN · award
HORN MARGARET A · award
PARKER H STEWART · award
MEYERS JAMES ROBERT · award
CAREY ROBERT F. · award
HILLAN KENNETH J. · award
SMITH KAREN LESLEY M.D. PH.D. · award
MACRAE SANDY · award
DURAIBABU PRATHYUSHA · award
WILLOUGHBY SCOTT B · award
DUBOIS-STRINGFELLOW NATHALIE · award
DAVIS GREGORY D · award
1 signals · latest 5d ago
Get alerted when SGMO changes direction
We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.